Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01699815 · ClinicalTrials.gov registry record · Phase 4
Time of Intravenous Acetaminophen Administration
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 126
- Enrollment target
NCT01699815 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 126 participants.
The verdict
NCT01699815, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 126 participants
- Enrollment target
Study Summary
The purpose of the study is to examine the effects of timing of administration of intravenous (IV) acetaminophen and how timing relates to analgesic efficacy as measured by postoperative pain scores. A maximum of 138 patients meeting inclusion criteria who present for a scheduled total hip replacement under general anesthesia will be randomized into one of two arms: 1) the pre-closure group will receive the first dose administered upon onset of skin closure, 2) the preemptive group will receive the first dose administered within 60 minutes prior to incision. Both groups will receive subsequent doses every 6 hours x 24 hours.
Interventions
- DRUG Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01699815
The ClinicalTrials.gov registry entry for NCT01699815 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acetaminophen is the first listed.
NCT01699815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01699815 about?
NCT01699815 is a clinical study titled "Time of Intravenous Acetaminophen Administration". The purpose of the study is to examine the effects of timing of administration of intravenous (IV) acetaminophen and how timing relates to analgesic efficacy as measured by postoperative pain scores. A maximum of 138 patients meeting inclusion criteria who present for a scheduled total hip replaceme...
What is the current status of trial NCT01699815?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 126 participants. The study started on 2012-10. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01699815?
The interventions under investigation include: Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT01699815?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.